Etiket: Pelabresib
SHARE IN FOCUS: Morphosys price slips after Pelabresib data on Tradegate
FRANKFURT (dpa-AFX Broker) – The study data for the cancer drug Pelabresib caused a lot of nervousness in MorphoSys shares on Tuesday morning. Recently the price slipped massively. At their…